Back
ImmunityBio 10K Form
Buy
72
IBRX
ImmunityBio
Last Price:
7.64
Seasonality Move:
15.15%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive IBRX News And Ratings
See the #1 stock for the next 7 days that we like better than IBRX
IBRX Financial Statistics
Sales & Book Value
Annual Sales: | $622K |
---|---|
Cash Flow: | $-108.24M |
Price / Cash Flow: | 0 |
Annual Sales: | $-1.02 |
Price / Book: | 0 |
Profitability
EPS (TTM): | -1.09000 |
---|---|
Net Income (TTM): | $-600.96M |
Gross Margin: | -- |
Return on Equity: | 0% |
Return on Assets: | -152.36% |
ImmunityBio Earnings Forecast
Key ImmunityBio Financial Ratios
- The Research & Development expenses have been 37,357.88% of Revenue.
- The Interest Expense is -22.15% of Operating Income.
- The Net Earning history of IBRX is -93,761.41% of Total Revenues.
- Per Share Earnings over the last 5 years have been positive in 0 years.
ImmunityBio Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Biotechnology |
Sector: | Health Care |
Current Symbol: | IBRX |
Website: | immunitybio.com |
Debt
Debt-to-Equity Ratio: | -0.99 |
---|---|
Current Ratio: | 3.64 |
Quick Ratio: | 3.21 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
IBRX Technical Analysis vs Fundamental Analysis
Buy
72
ImmunityBio (IBRX)
is a Buy
Is ImmunityBio a Buy or a Sell?
-
ImmunityBio stock is rated a Buy
The current ImmunityBio [IBRX] share price is $7.65. The Score for IBRX is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.